Talk to Gani about these topics and more:

• Oncology clinical trials (early phase to post approval)
• Oncology medical affairs
• Pharmaceutical, academic and regulatory interactions

Talk to John about these topics and more:

• Tactics for driving health innovation
• Optimizing market access strategies for new therapies
• Demonstrating value through HEOR
• Drug development life cycle strategies

Talk to Tara about these topics and more: 

• Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
• Best practices in clinical data science and biometrics operations
• Clinical trial design and interim analysis
• Biostatistical consulting and regulatory interaction

Talk to Dr. Beske about these topics and more: 

• Cell line development 
• Leap-In Transposase and Transposons 

Talk to Dr. Gustafsson about these topics and more: 

•  GPS Platform 
• Protein Engineering 
• AI Machine Learning 
• Protein Analytics 

Talk to Jay about these topics and more:

• Understanding cardiac safety requirements, including protocol design 
• Sponsor support at FDA meetings 
• Early phase development 
• Working with data and safety monitoring boards 
• Cardiac arrhythmias and electrophysiology  

Talk to Cassie about these topics and more:

• Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct 
• Efficiencies and guidance in running Phase 1 of clinical development  
• Understanding cardiac safety requirements and the best cost-saving methods 
• Developing new service programs as needs emerge 
• Rapid operational scaling/growth, strategic planning, and recapitalization